Literature DB >> 11487197

The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

V Bonifati1, G De Michele, C B Lücking, A Dürr, E Fabrizio, G Ambrosio, N Vanacore, M De Mari, R Marconi, L Capus, M M Breteler, T Gasser, B Oostra, N Wood, Y Agid, A Filla, G Meco, A Brice.   

Abstract

Mutations of the parkin gene on chromosome 6 cause autosomal recessive, early onset parkinsonism. This is the most frequent form of monogenic parkinsonism so far identified. The associated phenotypical spectrum encompasses early onset, levodopa-responsive parkinsonism (average onset in the early 30s in Europe), and it overlaps with dopa-responsive dystonia in cases with the earliest onset, and with clinically typical Parkinson's disease in cases with later onset. Despite clinical features, Lewy bodies are not found at autopsy in brains of patients with parkin mutations. The parkin protein possesses ubiquitin ligase activity, which is abolished by the pathogenic mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487197     DOI: 10.1007/s100720170042

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Parkin transcript variants in rat and human brain.

Authors:  Velia Dagata; Sebastiano Cavallaro
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

2.  Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.

Authors:  Anna De Rosa; Teresa Pellegrino; Sabina Pappatà; Maria Teresa Pellecchia; Silvio Peluso; Francesco Saccà; Paolo Barone; Alberto Cuocolo; Giuseppe De Michele
Journal:  J Nucl Cardiol       Date:  2015-12-01       Impact factor: 5.952

Review 3.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.

Authors:  Oscar Bernal-Pacheco; Genko Oyama; Angela Briton; Andrew B Singleton; Hubert H Fernandez; Ramon L Rodriguez; Irene A Malaty; Michael S Okun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-10-10

Review 5.  Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.

Authors:  Darren J Moore; Valina L Dawson; Ted M Dawson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

6.  Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.

Authors:  Ronny Myhre; Stina Steinkjer; Alice Stormyr; Gina L Nilsen; Hiba Abu Zayyad; Khalid Horany; Mohamad K Nusier; Helge Klungland
Journal:  BMC Neurol       Date:  2008-12-16       Impact factor: 2.474

7.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 8.  Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).

Authors:  Zhi Dong Zhou; Sushmitha Sathiyamoorthy; Dario C Angeles; Eng King Tan
Journal:  Mol Brain       Date:  2016-04-18       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.